Decreased susceptibility to antibiotic killing of a stable small colony variant of Staphylococcus aureus in fluid phase and on fibronectin-coated surfaces

Journal of Antimicrobial Chemotherapy

Volumn 39, Issue 5, 1997, Pages 603-608

  Chuard, Christian ^a   Vaudaux, Pierre E ^b   Proctor, Richard A ^c   Lew, Daniel P ^c  

^a Hopital Cantonal de Fribourg   (Switzerland)

^b Faculty of Medicine   (Switzerland)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; FIBRONECTIN; FLEROXACIN; HEMIN; MENADIONE; OXACILLIN; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL CELL WALL; BACTERIAL COUNT; BACTERIAL GROWTH; BACTERIAL METABOLISM; BACTERICIDAL ACTIVITY; BACTERIUM CULTURE; BIOSYNTHESIS; CELL SUSPENSION; CONTROLLED STUDY; ELECTRON TRANSPORT; LIQUID; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHENOTYPE; RELAPSE; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; STRAIN DIFFERENCE;

ANTI-BACTERIAL AGENTS; FIBRONECTINS; MICROBIAL SENSITIVITY TESTS; STAPHYLOCOCCUS AUREUS;

EID: 0030961303     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/39.5.603     Document Type: Article

References (30)

1. Acar, J. F., Goldstein, F. W. & Lagrange, P. (1978). Human infections caused by thiamine- or menadione-requiring Staphylococcus aureus. Journal of Clinical Microbiology 8, 142-7.
2. Goudie, J. G. & Goudie, R. B. (1955). Recurrent infections by a stable dwarf-colony variant of Staphylococcus aureus. Journal of Clinical Pathology 8, 284-7.
3. Hale, J. H. (1947). Studies on Staphylococcus mutation: characteristics of the "G" (gonidial) variant and factors concerned in its production. British Journal of Experimental Pathology 28, 202-10.
4. Kaplan, M. L. & Dye, W. E. (1976). Growth requirements of some small-colony-forming variants of Staphylococcus aureus. Journal of Clinical Microbiology 4, 343-8.
5. Quie, P. G. (1969). Microcolonies (G-variants) of Staphylococeus aureus. Yale Journal of Biology and Medicine 41, 349-403.
6. Sherris, J. C. (1952). Two small colony variants of Staphylococcus aureus isolated in pure culture from closed infected lesions and their carbon dioxide requirements. Journal of Clinical Pathology 5, 354-5.
7. 2-dependent Staphylococcus. Journal of Clinical Pathology 8, 288-91.
8. Wise, R. I. (1956). Small colonies (G variants) of staphylococci: isolation from cultures and infections. Annals of the New York Academy of Sciences 65, 169-74.
9. Yegian, D., Gallo, G. & Toll, M. W. (1959). Kanamycin resistant Staphylococcus mutants requiring heme for growth. Journal of Bacteriology 78, 10-2.
10. Proctor, R. A., van Langevelde, P., Kristjansson, M., Maslow, J. N. & Arbeit, R. D. (1995). Persistent and relapsing infections associated with small-colony variants of Staphylococcus aureus. Clinical Infectious Diseases 20, 95-102.
11. Baddour, L. M., Simpson, W. A., Weems, J. J., Hill, M. M. & Christensen, G. D. (1988). Phenotypic selection of small-colony variant forms of Staphylococcus epidermidis in the rat model of endocarditis. Journal of Infectious Diseases 157, 757-63.
12. Chambers, H. F. & Miller, M. H. (1987). Emergence of resistance to cephalothin and gentamicin during combination therapy for methicillin-resistant Staphylococcus aureus endocarditis in rabbits. Journal of Infectious Diseases 155, 581-5.
13. Proctor, R. A. (1994). Microbial pathogenic factors: small colony variants. In Infections Associated with Indwelling Medical Devices, 2nd edn (Bisno, A. L. & Waldvogel, F. A., Eds), pp. 79-90. American Society for Microbiology, Washington, DC.
14. Proctor, R. A., Balwit, J. M. & Vesga, O. (1994), Variant subpopulations of Staphylococcus aureus as cause of persistent and recurrent infections. Infectious Agents and Disease 3, 302-12.
15. Balwit, J. M., van Langevelde, P., Vann, J. M. & Proctor, R. A. (1994). Gentamicin-resistant menadione and hemin auxotrophic Staphylococcus aureus persist within cultured endothelial cells. Journal of Infectious Diseases 170 1033-7.
16. Vesga, O., Groeschel, M. C., Otten, M. F., Brar, D. W., Vann, J. M. & Proctor, R. A. (1996). Staphylococcus aureus small colony variants are induced by the endothelial cell intracellular milieu. Journal of Infectious Diseases 173,. 739-42.
17. Miller, M, H., Wexler, M. A. & Steigbigel, N. H. (1978). Single and combination antibiotic therapy of Staphylococcus aureus experimental endocarditis; emergence of gentamicin-resistant mutants. Antimicrobial Agents and Chemotherapy 14, 336-43.
18. Musher, D. M., Baughn, R. E., Templeton, G. B. & Minuth, J. N. (1977). Emergence of variant forms of Staphylococcus aureus after exposure to gentamicin and infectivity of the variants in experimental animals. Journal of Infectious Diseases 136, 360-9.
19. Lewis, L. A., Li, K., Bharosay, M., Cannella, M., Jorgenson, V., Thomas, R. et al. (1990). Characterization of gentamicin-resistant respiratory-deficient (res-) variant strains of Staphylococcus aureus. Microbiology and Immunology, 34, 587-605.
20. Miller, M. H., Edberg, S. C., Mandel, L. J., Behar, C. F. & Steigbigel, N. H. (1980). Gentamicin uptake in wild-type and aminoglycoside-resistant small-colony mutants of Staphylococcus aureus. Antimicrobial Agents and Chemotherapy 18, 722-9.
21. Pelletier, L. L., Richardson, M. & Feist, M. (1979). Virulent gentamicin-induced small colony variants of Staphylococcus aureus. Journal of Laboratory and Clinical Medicine 94, 324-34.
22. Bryan, L. E. & Van Den Elzen, H. M. (1977). Effects of membrane-energy mutations and cations on streptomycin and gentamicin accumulation by bacteria: a model for entry of streptomycin and gentamicin in susceptible and resistant bacteria, Antimicrobial Agents and Chemotherapy 12, 163-77.
23. Chuard, C., Vaudaux, P., Waldvogel, F. A. & Lew, D. P. (1993), Susceptibility of Staphylococcus aureus growing on fibronectin-coated surfaces to bactericidal antibiotics. Antimicrobial Agents and Chemotherapy 37, 625-32.
24. Widmer, A. F., Wiestner, A., Frei, R. & Zimmerli, W. (1991). Killing of nongrowing and adherent Escherichia coli determines drug efficacy in device-related infections, Antimicrobial Agents and Chemotherapy 35, 741-6.
25. Evans, D. J., Allison, D. G., Brown, M. R. & Gilbert, P. (1991). Susceptibility of Pseudomonas aeruginosa and Escherichia coli biofilms towards ciprofloxacin: effect of specific growth rate. Journal of Antimicrobial Chemotherapy 27, 177-84.
26. Brown, M. R., Collier, P. J. & Gilbert, P. (1990). Influence of growth rate on susceptibility to antimicrobial agents: modification of the cell envelope and batch and continuous culture studies. Antimicrobial Agents and Chemotherapy 34, 1623-8.
27. Eng, R. H. K., Hsieh, A. & Smith, S. M. (1995). Antibiotic killing of bacteria: comparison of bacteria on surfaces and in liquid, growing and nongrowing. Chemotherapy (Basel) 41, 113-20.
28. National Committee for Clinical Laboratory Standards, (1990), Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically-Second Edition; Approved Standard M7-A2. NCCLS, Villanova, PA.
29. National Committee for Clinical Laboratory Standards. (1987). Methods for Determining Bactericidal Activity of Antimicrobial Agents', Proposed Guideline M26-P. NCCLS, Villanova, PA.
30. Eng, R. H. K., Padberg, F. T., Smith, S. M., Tan, E. N, & Cherubin, C. E. (1991). Bactericidal effects of antibiotics on slowly growing and nongrowing bacteria. Antimicrobial Agents and Chemotherapy 35, 1824-8.